Generics Bulletin is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Teva Introduces First Sabril Rival In US

Executive Summary

Teva has introduced the first generic version of Lundbeck’s Sabril 500mg tablets in the US, less than a month after obtaining FDA approval for the drug.

Advertisement

Related Content

Dr Reddy's Brings In Kikuchi To Lead North America Generics
First Sabril Rival Sees FDA Deliver On Prioritizing Competition
Teva first in the US with a rival to Cialis
Mylan has head start on US Adcirca rival

Topics

What to read next

Advertisement
UsernamePublicRestriction

Register

GB140067

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel